A patient database to boost Parkinson's research
The Howard Florey Institute and Parkinson's Victoria have teamed up to establish the Parkinson's Victoria Research Register (PVRR) "” a living patient database for Parkinson's disease (PD), the nation's second most common, chronic neurological condition.
The database is hoped to improve research by helping the medical industry investigate possible causes, assess the condition's progress, analyse the diversity of symptoms and develop better symptom management.
Current estimates indicate that between 54,000 and 80,000 Australians are currently living with PD, with 25 new cases diagnosed every day.
The register will facilitate faster and more effective drug development for a condition where medication is integral to symptom management.
Prof Malcolm Horne from the Howard Florey Institute said the register would overcome difficulties associated with current patient-involved research.
"The symptoms and effect of PD vary greatly and patients also vary in the course of the disease and their response to medication. This database will include these details, as well as information about genetics, DNA and other biochemical data," Horne said.
"This type of information is invaluable for trials of new medications and for studying why people have the disease or have different severity of symptoms. The clinical outcomes will be significant and open up new avenues of PD research, while also improving our understanding of the condition and the development of diagnostic testing.
"When fully operational, the register will assist us in our search for a cure for this devastating brain disorder, which can affect any adult of any age," he said.
The register will consist of 300 participants whose condition, medical records and disease progression will be described in detail. A control group, ideally the partners of the participants, will be matched on age and environment and will also form part of the register.
To maintain the credibility and value of the register, strict selection criteria will be used and participants will be chosen ranging from recently diagnosed subjects, through to those who have lived with the condition for 15 years or more.
The register will encompass a range of demographics (age, ethnicity, postcode), and new participants will be recruited each year to ensure the register remains at around 300.
Experimental blood test detects early-stage pancreatic cancer
The new test works by detecting two sugars — CA199.STRA and CA19-9 — that are...
Biomarkers for dementia vary with time of day
Biomarkers used to diagnose Alzheimer's, including a promising marker for early diagnosis of...
Soundwaves stimulate plant growth-promoting fungus
Scientists are using soundwaves in soil to aid ecosystem recovery, demonstrating the benefits of...